Progress in systemic sclerosis: novel therapeutic paradigms.
Varga
J
J
Section of Rheumatology (M/C733), University of Illinois at Chicago College of Medicine, 1158 Molecular Biology Research Building, 900 South Ashland Avenue, Chicago, IL 60607, USA. jvarga@uic.edu
D000818:Animals; D018849:Controlled Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000037:antagonists & inhibitors*; D007372:Interferons / Q000008:administration & dosage; D008297:Male; D011379:Prognosis; D011658:Pulmonary Fibrosis / Q000175:diagnosis / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000175:diagnosis / Q000188:drug therapy*; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors*; D016896:Treatment Outcome
D016212:Transforming Growth Factor beta; D007371:Interferon-gamma; D007372:Interferons